Insulin Pharmacokinetics

Where adjustments of diet, physical activity, and dosage of insulin are well known to diabetologists and diabetic patients, present-day knowledge of factors of importance to the pharmacokinetics of insulin is frequently ignored. The pharmacokinetics of insulin comprise the absorption process, the distribution including binding to circulating insulin antibodies, if present, and to insulin receptors, and its ultimate degradation and excretion. The distribution and metabolism of absorbed insulin follow that of endogenous insulin. The distribution and metabolism cannot be actively changed, except in the case of circulating insulin antibodies, which in rare cases also may cause insulin resistance. The use of insulin preparation of low immunogeneity will avoid or reduce this course of variation in action. The absorption process, the detailed mechanisms of which are still unknown, is influenced by many variables where some can be controlled, thereby reducing the intrapatient variability in insulin absorption, which may reach 35%, causing a corresponding metabolic lability. Besides the known differences in timing among different preparations, the size of dose, the injected volume, and the insulin concentration are determinants of absorption role. Fortuitous injection technique contributes to variance, as do changes in blood flow of the injected tissue. This may be induced by changes in ambient temperature, exercise of injected limb, or local massage. Regional differences are also due to differences in blood flow. Serum insulin peaks may peak up to 1 h after injection of soluble insulin into the thigh versus into the abdominal wall. Local degradation of insulin seems of less importance but may, in rare cases, be the cause of high insulin “requirements.” Available evidence is reviewed and the importance of implementing the consequences in the daily care of the insulin-treated patient is emphasized.

[1]  O. Wieland,et al.  Free insulin, bound insulin, C‐peptide and the metabolic control in juvenile onset diabetics: comparison of C‐peptide secretors and non‐secretors during 24 hours conventional insulin therapy , 1979, European journal of clinical investigation.

[2]  J. Schou.  Subcutaneous and Intramuscular Injection of Drugs , 1971 .

[3]  J. Davidson,et al.  Factors Influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin Mixtures , 1981, Diabetes Care.

[4]  U. Fischer,et al.  Absorption rates of subcutaneously injected insulin in the dog as calculated from the plasma insulin levels by means of a simple mathematical model , 1983, Diabetologia.

[5]  J. Cameron,et al.  THE ROUTE OF INSULIN ADMINISTRATION IN THE MANAGEMENT OF DIABETES MELLITUS. , 1964, The Journal of pediatrics.

[6]  T. M. Hayes,et al.  Human insulin: study of safety and efficacy in man. , 1981, British medical journal.

[7]  G. Dimitriadis,et al.  Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus , 1983, Diabetes Care.

[8]  R. D. Evans,et al.  THE ABSORPTION RATES OF INSULIN, GLOBIN INSULIN AND PROTAMINE ZINC INSULIN LABELLED WITH RADIOACTIVE IODINE , 1943 .

[9]  C. Eastman,et al.  Evidence for insulin degradation by muscle and fat tissue in an insulin resistant diabetic patient , 1982, Diabetologia.

[10]  Philip C. Johnson,et al.  Absorption of 131-I labeled modified insulin , 1967 .

[11]  P. Swift,et al.  Change to U-100 insulin does not appear to affect insulin absorption. , 1983, British medical journal.

[12]  T. Chalmers,et al.  Variability in absorption of insulin-I 131 in normal and diabetic subjects after subcutaneous and intramuscular injection. , 1959, The Journal of clinical investigation.

[13]  S. Gammeltoft,et al.  The biological properties of human insulin. Subcutaneous absorption, receptor binding and the clinical effect in diabetics assessed by a new statistical method. , 2009, Acta medica Scandinavica.

[14]  J. Galloway,et al.  A Comparison of Acid Regular and Neutral Regular Insulin: Responses of Normal Fasted Subjects to Varying Doses of Regular Insulin , 1973, Diabetes.

[15]  V. Koivisto.  Sauna-induced acceleration in insulin absorption from subcutaneous injection site. , 1980, British medical journal.

[16]  P. Felig,et al.  A rise in ambient temperature augments insulin absorption in diabetic patients. , 1981, Metabolism: clinical and experimental.

[17]  C. Joiner.  Rate of clearance of insulin labelled with 131 I from the subcutaneous tissues in normal and diabetic subjects. , 1959, Lancet.

[18]  W. Duckworth,et al.  Accelerated Insulin Degradation: An Alternate Mechanism for Insulin Resistance , 1979, Diabetes Care.

[19]  Duration of the Action of Different Insulins , 1952, British medical journal.

[20]  G. Slama,et al.  Plasma Insulin and C-Peptide Levels During Continuous Subcutaneous Insulin Infusion , 1979, Diabetes Care.

[21]  P. Felig,et al.  Alterations in Insulin Absorption and in Blood Glucose Control Associated with Varying Insulin Injection Sites in Diabetic Patients , 1980, Annals of Internal Medicine.

[22]  W. Duckworth,et al.  Insulin Resistance Caused by Massive Degradation of Subcutaneous Insulin , 1979, Diabetes.

[23]  A H Clemens,et al.  Development of the Biostator Glucose clamping algorithm. , 1982, Clinical chemistry.

[24]  S. Berson,et al.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. , 1956, The Journal of clinical investigation.

[25]  G. Bailie,et al.  Do Diabetic Patients Inject Accurate Doses of Insulin? , 1981, Diabetes Care.

[26]  J. Parsons,et al.  Matched glucose responses to insulin administered subcutaneously and intravenously , 1980, Diabetologia.

[27]  L. Regeur,et al.  Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. , 1979, British medical journal.

[28]  J. Schlichtkrull.  THE ABSORPTION OF INSULIN , 1977, Acta paediatrica Scandinavica. Supplement.

[29]  K. Johansen,et al.  Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects. , 1984, Acta endocrinologica.

[30]  C. Binder,et al.  The absorption of soluble insulin correlated to the diabetic state. , 2009, Acta medica Scandinavica.

[31]  A. Keston,et al.  THE ABSORPTION AND DISTRIBUTION OF INSULIN LABELLED WITH RADIOACTIVE IODINE. , 1942, Science.

[32]  S. Madsbad,et al.  Smoking reduces insulin absorption from subcutaneous tissue. , 1982, British medical journal.

[33]  P. Halban,et al.  Biologic Activity and Pharmacokinetics of Biosynthetic Human Insulin in the Rat , 1981, Diabetes Care.

[34]  E. Froesch,et al.  Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: Blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels , 1982, Diabetologia.

[35]  N. White,et al.  Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. , 1981, The New England journal of medicine.

[36]  P. Dandona,et al.  LOW-DOSE INSULIN INFUSIONS IN DIABETIC PATIENTS WITH HIGH INSULIN REQUIREMENTS , 1978, The Lancet.

[37]  R. W. Stevenson.  Subcutaneous degradation of insulin , 1982, Diabetologia.

[38]  A E Lambert,et al.  Determination of Insulin Requirements in Brittle Diabetic Patients by the Artificial Pancreas , 1978, Diabetes.

[39]  T. Kobayashi,et al.  The Pharmacokinetics of Insulin After Continuous Subcutaneous Infusion or Bolus Subcutaneous Injection in Diabetic Patients , 1983, Diabetes.

[40]  P. Halban,et al.  RESISTANCE AGAINST SUBCUTANEOUS INSULIN SUCCESSFULLY MANAGED WITH APROTININ , 1980, The Lancet.

[41]  M. C. Balodimos,et al.  ABSORPITION OF INSULIN‐I131 FROM SUBCUTANEOUS TISSUE IN DIABETIC PATIENTS , 1962, The American journal of the medical sciences.

[42]  R. Chez,et al.  Use of Jet Insulin Injection in Diabetes Mellitus Therapy , 1972, Diabetes.

[43]  W. Clarke,et al.  Clinical evaluation and preliminary studies on the use of an artificial pancreatic beta cell in juvenile diabetes mellitus. , 1977, The Journal of pediatrics.

[44]  H. Cüppers,et al.  Exercise-induced Fall of Blood Glucose in Insulin-treated Diabetics Unrelated to Alteration of Insulin Mobilization , 1979, Diabetes.

[45]  R. Dillon.  Improved Serum Insulin Profiles in Diabetic Individuals Who Massaged Their Insulin Injection Sites , 1983, Diabetes Care.

[46]  T. Deckert,et al.  Absorption and Miscibility of Regular Porcine Insulin After Subcutaneous Injection of Insulin-treated Diabetic Patients , 1983, Diabetes Care.

[47]  C. Binder,et al.  The Absorption of an Acid and a Neutral Insulin Solution after Subcutaneous Injection into Different Regions in Diabetic Patients , 1967 .

[48]  R. Baxter,et al.  Equilibrium binding studies of insulin antibodies in diabetic subjects. , 1976, Clinical chemistry.

[49]  D. Citrin,et al.  DEFECTIVE ABSORPTION OF INJECTED INSULIN , 1978, The Lancet.

[50]  J. Nabarro,et al.  Circulating insulin-binding antibodies , 1980, Diabetologia.

[51]  K. Alberti,et al.  A comparison between diabetics receiving a high or low daily insulin dosage. , 1978, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[52]  A. Kitabchi,et al.  Comparison of the effectiveness of various routes of insulin injection: insulin levels and glucose response in normal subjects. , 1976, The Journal of clinical endocrinology and metabolism.

[53]  T. Deckert.  Intermediate-acting Insulin Preparations: NPH and Lente , 1980, Diabetes Care.

[54]  D. Diederich,et al.  DISAPPEARANCE OF I-131-LABELED INSULIN FROM PLASMA AS A GUIDE TO MANAGEMENT OF DIABETES. , 1964, The New England journal of medicine.

[55]  P. Felig,et al.  Effects of leg exercise on insulin absorption in diabetic patients. , 1978, The New England journal of medicine.

[56]  R. D. Evans,et al.  Absorption of insulin labeled with radioactive iodine in human diabetes. , 1944 .

[57]  F. Enzmann,et al.  Comparison of Biosynthetic Human Insulin and Pork Insulin in the Gerritzen Test , 1981, Diabetes Care.

[58]  P. Aaby,et al.  Absorption, effectiveness and side effects of highly purified porcine NPH-insulin preparations (Leo®) , 1978, European Journal of Clinical Pharmacology.

[59]  D. Goldie,et al.  The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics. , 1978, Acta Endocrinologica.

[60]  K. Alberti,et al.  Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption. , 1981, British medical journal.

[61]  E. Almira,et al.  Insulin degradation in serum of a patient with apparent insulin resistance. , 1981, The Journal of clinical endocrinology and metabolism.

[62]  E. Ferrannini,et al.  Effect of bicycle exercise on insulin absorption and subcutaneous blood flow in the normal subject. , 1982, Clinical physiology.

[63]  P. Halban,et al.  Pharmacokinetics of Subcutaneously Injected Tritiated Insulin: Effects of Exercise , 1979, Diabetes.

[64]  T. Deckert,et al.  INSULIN ABSORPTION AND INSULIN REQUIREMENT , 1978, The Lancet.

[65]  T. M. Hayes,et al.  COMPARATIVE STUDY OF SUBCUTANEOUS, INTRAMUSCULAR, AND INTRAVENOUS ADMINISTRATION OF HUMAN INSULIN , 1981, The Lancet.

[66]  E W Kraegen,et al.  Programming of Insulin Delivery with Meals During Subcutaneous Insulin Infusion , 1981, Diabetes Care.

[67]  A H Clemens,et al.  Control of blood sugar in insulin-dependent diabetes: comparison of an artificial endocrine pancreas, continuous subcutaneous insulin infusion, and intensified conventional insulin therapy. , 1980, The New England journal of medicine.

[68]  S A BERSON,et al.  Quantitative aspects of the reaction between insulin and insulin-binding antibody. , 1959, The Journal of clinical investigation.

[69]  J. Pearson,et al.  V. Studies with Insulin Labelled with Iodine 131 , 1959 .

[70]  P. Bottermann,et al.  Pharmacokinetics of Biosynthetic Human Insulin and Characteristics of Its Effect , 1981, Diabetes Care.

[71]  T. Deckert,et al.  Clinical Factors Influencing the Absorption of 125I-NPH Insulin in Diabetic Patients , 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[72]  T. Lauritzen,et al.  Absorption of isophane (NPH) insulin and its clinical implications. , 1982, British medical journal.

[73]  M. Hartog,et al.  The accuracy of drawing up insulin by insulin treated diabetics. , 1982, Diabete & metabolisme.

[74]  K. Dixon.  Measurement of antibodies on insulin in serum. , 1974, Clinical chemistry.

[75]  J. Pickup,et al.  INSULIN VIA CONTINUOUS SUBCUTANEOUS INFUSION , 1978, The Lancet.

[76]  M. Shahshahani,et al.  Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients. , 1978, The Journal of clinical endocrinology and metabolism.

[77]  P. Halban,et al.  The Effect of Aprotinin on the Absorption of Subcutaneously Injected Regular Insulin in Normal Subjects , 1980, Diabetes.

[78]  P. Halban,et al.  The preparation of a semisynthetic tritiated insulin with a specific radioactivity of up to 20 Curies per millimole. , 1975, The Biochemical journal.

[79]  J Seydoux,et al.  Absorption kinetics of subcutaneously injected insulin , 1979, Diabetologia.

[80]  C. Binder,et al.  Pharmacokinetics of continuous subcutaneous insulin infusion , 1983, Diabetologia.

[81]  A. Kinmonth,et al.  Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children , 1980, British medical journal.

[82]  V. Jörgens,et al.  Absorption Kinetics and Biologic Effects of Subcutaneously Injected Insulin Preparations , 1982, Diabetes Care.

[83]  T. Deckert,et al.  Absorption of NPH-insulin from subcutaneous tissue: a methodological study in pigs. , 2009, Acta pharmacologica et toxicologica.

[84]  O. Faber,et al.  IMPORTANCE OF INSULIN ABSORPTION, SUBCUTANEOUS BLOOD FLOW, AND RESIDUAL BETA‐CELL FUNCTION IN INSULIN THERAPY , 1980, Acta paediatrica Scandinavica. Supplement.

[85]  K. Alberti,et al.  Plasma Free Insulin Profiles After Administration of Insulin by Jet and Conventional Syringe Injection , 1981, Diabetes Care.